| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |